Ozempic® and Your A1C: Navigating Eligibility for a Healthier Future

Last reviewed: June 23, 2026

Last updated: June 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Hemoglobin A1C—a measure of average blood glucose over three months—is a critical marker for diabetes risk and metabolic health. Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has become one of the most studied medications for improving A1C and supporting sustainable weight management. Understanding your A1C level and how semaglutide works can help you make an informed decision about whether this therapy aligns with your health goals.

Understanding A1C Levels and Semaglutide Eligibility

Your A1C percentage tells you how much glucose has attached to hemoglobin, your blood's oxygen-carrying protein, over the past 2–3 months. Most adults without diabetes have an A1C below 5.7%, while an A1C of 5.7–6.4% indicates prediabetes, and 6.5% or higher suggests type 2 diabetes. Semaglutide eligibility traditionally required either type 2 diabetes diagnosis or a BMI of 30 or higher with at least one weight-related condition, though compounded versions like those offered by PlexusDx may have different criteria based on individualized medical evaluation.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Semaglutide Lowers Blood Glucose and Improves A1C

Semaglutide mimics glucagon-like peptide-1 (GLP-1), a hormone that signals your pancreas to release insulin when blood glucose rises after eating. It also slows stomach emptying, reducing appetite signals sent to your brain, and helps your liver use glucose more efficiently. Together, these actions lower fasting glucose, reduce post-meal blood sugar spikes, and support steady glucose control over weeks and months—directly lowering your A1C measurement.

The medication works through two main pathways: the GLP-1 receptor on pancreatic beta cells increases insulin release, while activation of GLP-1 receptors in the brain's appetite centers decreases hunger and food intake. This dual action explains why patients often experience both improved glucose control and weight loss simultaneously. Individual genetic variations—such as the GLP1R rs6923761 variant—influence how efficiently your cells respond to semaglutide, which is why PlexusDx offers genetic testing to personalize your treatment plan.

PlexusDx Semaglutide Options and Monthly Pricing

PlexusDx offers compounded semaglutide injection at $189/mo month-to-month, or from $149/mo on the 6-month plan, with no insurance requirement and full eligibility for HSA and FSA accounts. The pricing remains flat regardless of your dose level—your dose may need to go up as your body adapts, but your price won't. This model removes barriers for patients seeking sustained GLP-1 therapy and eliminates the unpredictability of insurance coverage denials or tier-based copays.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Monitoring Your A1C Progress and Long-Term Success

Most patients recheck A1C levels 8–12 weeks after starting semaglutide to measure initial response, then every 3–6 months thereafter to track sustained improvement. Home glucose monitoring using a continuous glucose monitor (CGM) or finger-stick tests can help you see real-time changes in blood glucose patterns before your official A1C lab results. Keeping a simple food and activity log during your first 8 weeks helps identify which lifestyle changes have the greatest impact on your glucose control.

Long-term A1C success with semaglutide depends on medication consistency, dietary choices, physical activity, and sleep quality. PlexusDx supports this journey through personalized dosing plans and access to the Precision Peptide Genetic Test, which reveals whether your FTO rs9939609 or MC4R rs17782313 variants predispose you toward greater metabolic rigidity—information that can guide your exercise and nutrition strategy. Discontinuing semaglutide typically leads to A1C return toward baseline within 4–8 weeks, underscoring the importance of sustained commitment to your health plan.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What A1C level qualifies me for semaglutide treatment?

Traditionally, type 2 diabetes (A1C ≥6.5%) or prediabetes with obesity qualified patients for semaglutide. However, PlexusDx offers compounded semaglutide with individualized medical evaluation, so eligibility may extend to those with lower A1C levels seeking metabolic optimization. A licensed PlexusDx provider can review your specific A1C, medical history, and goals to determine candidacy.

How much will my A1C drop if I take semaglutide?

Most patients experience A1C reductions of 1–2 percentage points within 8–12 weeks, though individual results vary based on baseline A1C, dose, adherence, and lifestyle. PlexusDx's Precision Peptide Genetic Test identifies genetic factors—like GIPR variants—that influence your expected response magnitude, helping set realistic expectations for your personalized plan.

How much does PlexusDx semaglutide cost per month?

PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) with flat pricing across all dose levels. No insurance, membership fees, or HSA/FSA restrictions apply. Oral semaglutide is available at $289/mo (or $249/mo on the 6-month plan), with the Precision Peptide Genetic Test available for $298.

Is compounded semaglutide as effective as brand-name Ozempic®?

PlexusDx compounded semaglutide comes from licensed 503A compounding pharmacies meeting pharmaceutical-grade standards for purity and potency. While compounded medications are not FDA-approved (unlike brand Ozempic®), quality-assured compounding provides cost-effective access and equivalent clinical outcomes when prescribed appropriately.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

Yes. PlexusDx's Precision Peptide Genetic Test analyzes 14 metabolic pathways and identifies key variants like GIPR rs1800437, and FTO rs9939609 that influence glucose metabolism and semaglutide response. This $298 test helps your provider tailor your dose and lifestyle strategy for maximum A1C improvement.

Related Reading

• Lifemd Ozempic
• Eden Ozempic
• Ro Ozempic
• Mochi Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.